Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
41 participants
OBSERVATIONAL
2009-06-30
2016-04-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Subjects meeting the entrance criteria specified in this protocol will be randomized as they become available.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study
NCT01107340
AMIStem-H Radiographic Analysis
NCT02829866
Polarstem Versus Corail; a Comparison of Micromotion and Periprosthetic Bone Remodelling of Two Femoral Stems
NCT05815953
Evaluate the Effect of Osteo Introducer System in Total Hip Arthroplasty
NCT03113591
Evaluation of Fixation Achievable in Revision Total Knee Arthroplasty Implementing Latest-Generation Implant Technology
NCT03276351
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MIS Femoral Neck Stem
Subject will be randomized to either MIS or Synergy implant.
MIS Femoral Neck Stem implant
Synergy Hip System
Subject will be randomized to either Synergy or MIS implant.
MIS Femoral Neck Stem implant
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MIS Femoral Neck Stem implant
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is willing to consent to participation in the study.
* Subject plans to be available for follow-up through study duration.
* Subject is of stable health and is free of or treated and stabilized for any condition that would prose excessive operating risk.
Exclusion Criteria
* Subject has had major non-arthroscopic surgery to the study hip.
* Subject has physical, emotional or neurological conditions that would compromise the subjects compliance with postoperative rehabilitation and follow-up.
* Subject has a known sensitivity to materials in the device.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Smith & Nephew, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard McCalden, MD
Role: PRINCIPAL_INVESTIGATOR
London Health Science Center
Beate Hanson, MD, PhD
Role: STUDY_CHAIR
Vice President, Global Clinical Strategy and Global Clinical Operations
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
London Health Sciences Center- University Hospital
London, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
US-CR-130
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.